• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肌炎患者外周血中的干扰素特征与疾病活动相关。

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.

作者信息

Baechler Emily C, Bauer Jason W, Slattery Catherine A, Ortmann Ward A, Espe Karl J, Novitzke Jill, Ytterberg Steven R, Gregersen Peter K, Behrens Timothy W, Reed Ann M

机构信息

University of Minnesota Medical School, Minneapolis, MN 55455, USA.

出版信息

Mol Med. 2007 Jan-Feb;13(1-2):59-68. doi: 10.2119/2006-00085.Baechler.

DOI:10.2119/2006-00085.Baechler
PMID:17515957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1869622/
Abstract

Recent studies have shown increased expression of interferon (IFN)-regulated genes in the peripheral blood cells of patients with systemic lupus erythematosus. A similar interferon signature has been observed in affected muscle tissue from patients with dermatomyositis (DM), but it has not yet been determined if this signature extends to the peripheral blood in DM. We performed global gene expression profiling of peripheral blood cells from adult and juvenile DM patients and healthy controls. Several interesting groups of genes were differentially expressed in DM, including genes with immune function, and others that function in muscle or are involved in mitochondrial/oxidative phosphorylation. Investigation of type I IFN-regulated transcripts revealed a striking interferon signature present in most DM patients studied. Levels of type I IFN-regulated proteins were also elevated in DM serum samples. Furthermore, both the transcript and serum protein IFN signatures were associated with disease activity. These data suggest that the IFN signature may be a useful marker for DM disease activity, and that sampling peripheral blood may be a more practical alternative to muscle biopsy for measuring this signature.

摘要

近期研究表明,系统性红斑狼疮患者外周血细胞中干扰素(IFN)调节基因的表达增加。在皮肌炎(DM)患者的受累肌肉组织中也观察到了类似的干扰素特征,但这种特征是否延伸至DM患者的外周血尚未确定。我们对成年和青少年DM患者及健康对照者的外周血细胞进行了全基因组表达谱分析。在DM中,有几组有趣的基因存在差异表达,包括具有免疫功能的基因,以及在肌肉中发挥作用或参与线粒体/氧化磷酸化的其他基因。对I型干扰素调节转录本的研究发现,在大多数研究的DM患者中存在显著的干扰素特征。DM血清样本中I型干扰素调节蛋白的水平也升高。此外,转录本和血清蛋白干扰素特征均与疾病活动相关。这些数据表明,干扰素特征可能是DM疾病活动的有用标志物,并且对于测量这种特征,采集外周血可能是比肌肉活检更实用的替代方法。

相似文献

1
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.皮肌炎患者外周血中的干扰素特征与疾病活动相关。
Mol Med. 2007 Jan-Feb;13(1-2):59-68. doi: 10.2119/2006-00085.Baechler.
2
Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.白细胞介素-6、I型干扰素调节基因和趋化因子可标志皮肌炎的疾病活动度。
Arthritis Rheum. 2009 Nov;60(11):3436-46. doi: 10.1002/art.24936.
3
Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.皮肌炎中皮肤疾病活动与 1 型干扰素基因特征和干扰素-β的相关性。
Br J Dermatol. 2017 May;176(5):1224-1230. doi: 10.1111/bjd.15006. Epub 2017 Mar 14.
4
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.系统性红斑狼疮、皮肌炎、类风湿关节炎和硬皮病患者存在共同的 I 型干扰素途径激活。
Ann Rheum Dis. 2011 Nov;70(11):2029-36. doi: 10.1136/ard.2011.150326. Epub 2011 Jul 28.
5
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.Ⅰ型和Ⅱ型干扰素在幼年皮肌炎中的肌肉表达增加,并与临床和组织学特征相关。
Arthritis Rheumatol. 2019 Jun;71(6):1011-1021. doi: 10.1002/art.40800. Epub 2019 Apr 30.
6
Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course.青少年和成人皮肌炎中疾病活动新生物标志物的变化是疾病进程的敏感生物标志物。
Arthritis Rheum. 2012 Dec;64(12):4078-86. doi: 10.1002/art.34659.
7
Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.皮肌炎皮肤中的干扰素和生物学特征:疾病间的特异性和异质性。
PLoS One. 2012;7(1):e29161. doi: 10.1371/journal.pone.0029161. Epub 2012 Jan 3.
8
Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?自身免疫和病毒感染中细胞特异性I型干扰素特征:差异何在?
PLoS One. 2013 Dec 31;8(12):e83776. doi: 10.1371/journal.pone.0083776. eCollection 2013.
9
Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease.皮肌炎、系统性红斑狼疮和自身免疫性水疱病中逆转录转座子与 I 型干扰素及不同干扰素通路的协调作用。
Sci Rep. 2021 Nov 30;11(1):23146. doi: 10.1038/s41598-021-02522-6.
10
The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.宿主防御肽 LL-37 可能是多发性肌炎和皮肌炎患者 I 型干扰素系统的诱导剂。
J Autoimmun. 2017 Mar;78:46-56. doi: 10.1016/j.jaut.2016.12.003. Epub 2016 Dec 22.

引用本文的文献

1
Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature.患有IgA血管炎和川崎病的患者表现出干扰素特征失调。
Int J Rheum Dis. 2025 Jul;28(7):e70349. doi: 10.1111/1756-185X.70349.
2
Disease Activity-Dependent Siglec-1 Expression on Monocyte Subsets of Patients with Idiopathic Inflammatory Myopathies.特发性炎性肌病患者单核细胞亚群上疾病活动依赖性唾液酸结合免疫球蛋白样凝集素-1表达
Int J Mol Sci. 2025 May 21;26(10):4950. doi: 10.3390/ijms26104950.
3
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy.针对青少年皮肌炎中的干扰素反应:唾液酸结合免疫球蛋白样凝集素-1作为JAK抑制剂疗效的体外生物标志物
Rheumatology (Oxford). 2025 May 15. doi: 10.1093/rheumatology/keaf227.
4
Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders.分析I型和II型干扰素反应可揭示患有自身炎症性疾病的儿科患者的不同亚组。
J Allergy Clin Immunol Glob. 2025 Mar 8;4(2):100450. doi: 10.1016/j.jacig.2025.100450. eCollection 2025 May.
5
Tape strip expression profiling of juvenile dermatomyositis skin reveals mitochondrial dysfunction contributing to disease endotype.青少年皮肌炎皮肤的胶带条表达谱分析揭示线粒体功能障碍与疾病亚型相关。
JCI Insight. 2025 Mar 13;10(8). doi: 10.1172/jci.insight.179875. eCollection 2025 Apr 22.
6
Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.超敏干扰素定量分析揭示了炎性肌病中不同的细胞因子分泌谱,并且可作为皮肌炎活动的生物标志物。
Front Immunol. 2025 Feb 12;16:1529582. doi: 10.3389/fimmu.2025.1529582. eCollection 2025.
7
Type I interferon biomarker in idiopathic inflammatory myopathies: associations of Siglec-1 with disease activity and treatment response.特发性炎性肌病中的I型干扰素生物标志物:唾液酸结合免疫球蛋白样凝集素-1与疾病活动度及治疗反应的关联
Rheumatology (Oxford). 2025 May 1;64(5):2979-2986. doi: 10.1093/rheumatology/keae630.
8
Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis.成人类风湿性关节炎和幼年特发性关节炎患者血清蛋白质组学揭示的中性粒细胞和单核细胞白细胞途径及上游调控因子。
Arthritis Res Ther. 2024 Nov 11;26(1):196. doi: 10.1186/s13075-024-03421-7.
9
Pharmacological Strategies in Dermatomyositis: Current Treatments and Future Directions.皮肌炎的药理学策略:现有治疗方法和未来方向。
Med Sci Monit. 2024 Sep 14;30:e944564. doi: 10.12659/MSM.944564.
10
Subcellular location of L1 retrotransposon-encoded ORF1p, reverse transcription products, and DNA sensors in lupus granulocytes.狼疮粒细胞中L1逆转座子编码的ORF1p、逆转录产物和DNA传感器的亚细胞定位。
Mob DNA. 2024 Jun 27;15(1):14. doi: 10.1186/s13100-024-00324-x.

本文引用的文献

1
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.干扰素调节因子5(IRF5)的一种常见单倍型可调节剪接和表达,并与系统性红斑狼疮风险增加相关。
Nat Genet. 2006 May;38(5):550-5. doi: 10.1038/ng1782. Epub 2006 Apr 16.
2
Gene expression profiling in human autoimmunity.人类自身免疫中的基因表达谱分析。
Immunol Rev. 2006 Apr;210:120-37. doi: 10.1111/j.0105-2896.2006.00367.x.
3
Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis.外周血细胞的微阵列分析确定了银屑病关节炎中独特的基因表达特征。
Mol Med. 2005 Jan-Dec;11(1-12):21-9. doi: 10.2119/2006-00003.Gulko.
4
The type I interferon system in systemic lupus erythematosus.系统性红斑狼疮中的I型干扰素系统。
Arthritis Rheum. 2006 Feb;54(2):408-20. doi: 10.1002/art.21571.
5
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.特发性炎性肌病的免疫遗传风险和保护因素:不同的HLA - A、- B、- Cw、- DRB1和- DQA1等位基因谱及基序定义了高加索人的临床病理分组。
Medicine (Baltimore). 2005 Nov;84(6):338-349. doi: 10.1097/01.md.0000189818.63141.8c.
6
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies.特发性炎性肌病治疗试验的国际共识指南。
Arthritis Rheum. 2005 Sep;52(9):2607-15. doi: 10.1002/art.21291.
7
Peripheral blood gene expression profiling in rheumatoid arthritis.类风湿关节炎的外周血基因表达谱分析
Genes Immun. 2005 Aug;6(5):388-97. doi: 10.1038/sj.gene.6364209.
8
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.干扰素-α 通路的激活可识别出具有独特血清学特征和活动性疾病的系统性红斑狼疮患者亚组。
Arthritis Rheum. 2005 May;52(5):1491-503. doi: 10.1002/art.21031.
9
Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.炎症性肌病患者肌肉中的基因表达谱:静脉注射免疫球蛋白治疗的效果及临床相关基因的生物学验证
Brain. 2005 Aug;128(Pt 8):1887-96. doi: 10.1093/brain/awh518. Epub 2005 Apr 27.
10
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.α/β干扰素介导的皮肌炎先天性免疫机制
Ann Neurol. 2005 May;57(5):664-78. doi: 10.1002/ana.20464.